PRAXIS PRECISION MEDICINES, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $516.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $319.00K, a 24.12% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $197.00K, a 20.88% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $271.00K, a 11.52% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $263.00K, a 11.44% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.04M, a 11.47% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $933.00K, a 11.47% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $837.00K, a 11.30% increase from fiscal 2022.
- PRAXIS PRECISION MEDICINES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $752.00K, a 46.74% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $319.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $516.00K 10-Q · filed 2026-08-06 | $787.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $197.00K 10-Q · filed 2026-05-07 | $468.00K derived: sum of 2 quarters · filed 2026-05-07 | $731.00K derived: sum of 3 quarters · filed 2026-05-07 | $988.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $534.00K derived: sum of 2 quarters · filed 2026-02-19 | $791.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.04M 10-K · filed 2026-02-19 |
| 2025-09-30 | $263.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $520.00K derived: sum of 2 quarters · filed 2026-08-06 | $769.00K 10-Q · filed 2025-11-05 | $1.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $257.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $506.00K 10-Q · filed 2026-08-06 | $749.00K derived: sum of 3 quarters · filed 2026-08-06 | $985.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $249.00K 10-Q · filed 2026-05-07 | $492.00K derived: sum of 2 quarters · filed 2026-05-07 | $728.00K derived: sum of 3 quarters · filed 2026-05-07 | $958.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $479.00K derived: sum of 2 quarters · filed 2026-02-19 | $709.00K derived: sum of 3 quarters · filed 2026-02-19 | $933.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $466.00K derived: sum of 2 quarters · filed 2025-11-05 | $690.00K 10-Q · filed 2025-11-05 | $908.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $454.00K 10-Q · filed 2025-08-04 | $672.00K derived: sum of 3 quarters · filed 2026-02-19 | $884.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $224.00K 10-Q · filed 2025-05-02 | $442.00K derived: sum of 2 quarters · filed 2026-02-19 | $654.00K derived: sum of 3 quarters · filed 2026-02-19 | $860.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $430.00K derived: sum of 2 quarters · filed 2026-02-19 | $636.00K derived: sum of 3 quarters · filed 2026-02-19 | $837.00K 10-K · filed 2026-02-19 |
| 2023-09-30 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $418.00K derived: sum of 2 quarters · filed 2024-11-06 | $619.00K 10-Q · filed 2024-11-06 | $815.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $206.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $407.00K 10-Q · filed 2024-08-13 | $603.00K derived: sum of 3 quarters · filed 2024-08-13 | $793.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $201.00K 10-Q · filed 2024-05-13 | $397.00K derived: sum of 2 quarters · filed 2024-05-13 | $587.00K derived: sum of 3 quarters · filed 2024-05-13 | $773.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $386.00K derived: sum of 2 quarters · filed 2024-03-05 | $572.00K derived: sum of 3 quarters · filed 2024-03-05 | $752.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $376.00K derived: sum of 2 quarters · filed 2023-11-07 | $556.00K 10-Q · filed 2023-11-07 | $1.03M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $186.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $366.00K 10-Q · filed 2023-08-09 | $836.00K derived: sum of 3 quarters · filed 2023-08-09 | $1.30M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $180.00K 10-Q · filed 2023-05-11 | $650.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.12M derived: sum of 3 quarters · filed 2023-05-11 | $1.41M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $470.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $937.00K derived: sum of 2 quarters · filed 2023-02-07 | $1.23M derived: sum of 3 quarters · filed 2023-02-07 | $1.41M 10-K · filed 2023-02-07 |
| 2021-09-30 | $467.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $759.00K derived: sum of 2 quarters · filed 2022-11-09 | $942.00K 10-Q · filed 2022-11-09 | $1.12M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $292.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $475.00K 10-Q · filed 2022-08-08 | $654.00K derived: sum of 3 quarters · filed 2022-08-08 | $830.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $183.00K 10-Q · filed 2022-05-09 | $362.00K derived: sum of 2 quarters · filed 2022-05-09 | $538.00K derived: sum of 3 quarters · filed 2022-05-09 | $710.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $355.00K derived: sum of 2 quarters · filed 2022-02-28 | $527.00K derived: sum of 3 quarters · filed 2022-02-28 | $696.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $348.00K derived: sum of 2 quarters · filed 2021-11-03 | $517.00K 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $341.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $169.00K 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $642.00K 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |